A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics of BGT-002, a Novel ATP-Citrate Lyase Inhibitor, in Healthy Chinese Subjects

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics of BGT-002, a Novel ATP-Citrate Lyase Inhibitor, in Healthy Chinese Subjects

Yun Liu,1,2,* Chengyin Yu,1– 3,* Yifan Zhang,3 Zhifu Xie,3 Yating Wang,1,2 Hongjie Qian,1,2 Liyu Liang,1,2 Yanmei Liu,1,2 Qian Chen,1,2 Jingying Jia,1,2 Sai Yan,4 Xiaoyin Lai,4 Wei Li,4 Jingya Li,3 Yangming Zhang,4 Fajun Nan,3 Chen Yu1,2 1Shanghai Xuhui Central Hospital/Zhongshan-Xuh...

Full description

Bibliographic Details
Main Authors: Liu Y, Yu C, Zhang Y, Xie Z, Wang Y, Qian H, Liang L, Chen Q, Jia J, Yan S, Lai X, Li W, Li J, Nan F
Format: Article
Language:English
Published: Dove Medical Press 2025-03-01
Series:Drug Design, Development and Therapy
Subjects:
safety
tolerability
pharmacokinetics
pharmacodynamics
bgt-002
novel acly inhibitor.
Online Access:https://www.dovepress.com/a-phase-i-study-to-evaluate-the-safety-tolerability-pharmacokinetics-o-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/a-phase-i-study-to-evaluate-the-safety-tolerability-pharmacokinetics-o-peer-reviewed-fulltext-article-DDDT

Similar Items